AbbVie Inc. Total Operating Expenses 2011-2026 | ABBV
Beta
What is total operating expenses?
Total operating expenses include all costs related to running the core business, including cost of goods sold, R&D, and SG&A.
What is AbbVie Inc.'s current total operating expenses?
AbbVie Inc. (ABBV) annual total operating expenses for 2025 was $46.09B, a 2.36% decline from 2024. AbbVie Inc. total operating expenses for the quarter ending March 31, 2026 was $11.01B.
What was AbbVie Inc.'s total operating expenses in 2024?
AbbVie Inc. annual total operating expenses for 2024 was $47.20B, a 13.56% increase from 2023.
What was AbbVie Inc.'s total operating expenses in 2023?
AbbVie Inc. annual total operating expenses for 2023 was $41.56B, a 4.07% increase from 2022.
What is AbbVie Inc.'s 5-year total operating expenses CAGR?
AbbVie Inc. total operating expenses grew at a compound annual growth rate (CAGR) of 6.00% from FY2020 to FY2025, going from $34.44B to $46.09B over 5 years.
Total Operating Expenses History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+6.0%
FY2020
$34.44B
→
FY2025
$46.09B
111213141516171819202122232425
5 years selected
Total Operating Expenses History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $46.09B | -2.4% | 10-K |
| FY2024 | $47.20B | +13.6% | 10-K |
| FY2023 | $41.56B | +4.1% | 10-K |
| FY2022 | $39.94B | +4.3% | 10-K |
| FY2021 | $38.27B | +11.1% | 10-K |
| FY2020 | $34.44B | +69.8% | 10-K |
| FY2019 | $20.28B | -23.1% | 10-K |
| FY2018 | $26.37B | +41.2% | 10-K |
| FY2017 | $18.67B | +14.6% | 10-K |
| FY2016 | $16.30B | +6.4% | 10-K |
| FY2015 | $15.32B | -7.4% | 10-K |
| FY2014 | $16.55B | +26.1% | 10-K |
| FY2013 | $13.13B | +4.5% | 10-K |
| FY2012 | $12.56B | -9.1% | 10-K |
| FY2011 | $13.82B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →